EUVIMEDEUVIMED entdecken
Crossref

Design, Synthesis, Characterization, Molecular Modeling, and ADMET Analysis of Novel Quinazolin‐4(3 H )‐One‐Triazole Hybrids as Vasorelaxant Agent

Yassine Rhazi, Ismail Bouadid, Fatima Zahra Guerguer, Mohammed El Mesky, Aziz Arzine, Asmae Nakkabi, Mohamed Bakhouch iD, Noemi Deak, Samir Chtita, El Houssine Mabrouk, Gabriela Nemes, Mohamed El Yazidi und 1 weitere

Chemistry & Biodiversity · 2025

DOI: 10.1002/cbdv.202501062 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2025. Verfasst von Yassine Rhazi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Engineering Laboratory of Organometallic, Molecular and Environment, Faculty of Sciences Dhar EL Mahraz, Sidi Mohamed Ben Abdellah University, Fes, M…. Hauptthemen laut MEDLINE: Triazoles, Vasodilator Agents, Drug Design, Quinazolinones. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 77 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this study, a new series of quinazoline‐4(3 H )‐one–triazole hybrid derivatives 4a–e was synthesized via one pot click chemistry protocol, starting from N ‐alkyl bromo quinazolin‐4(3 H )‐one 2a–b and terminal alkynes 3a–e , achieving excellent yields and short reaction times. To confirm their structures, the compounds were characterized using several techniques, including proton and carbon nuclear magnetic resonance (NMR) spectroscopy, as well as high‐resolution mass spectrometry (HRMS). In vitro evaluations of vasorelaxant activity on isolated rat aortic rings precontracted by epinephrine (EP, 10 µM) revealed that all compounds exhibited a significant vasorelaxant activity compared with the reference drug, verapamil. absorption, distribution, metabolism, excretion, and toxicity (ADMET) properties prediction indicated a generally favorable pharmacokinetic profile, although some compounds showed potential risks of mutagenicity. Molecular docking analysis revealed high binding affinities with the protein target linked to vasorelaxant activity, with compound 3‐(10‐(4‐(hydroxymethyl)‐1 H ‐1,2,3‐triazol‐1‐yl)decyl)quinazolin‐4(3 H )‐one ( 4d ) showing greater stability in the active site than verapamil. In addition, molecular dynamics simulations confirmed that compound 4d enhances Cav1.1 protein stability, as evidenced by lower root mean square deviation (RMSD) values and reduced fluctuations, underlining its promise as an innovative therapeutic candidate for hypertension management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TriazolesVasodilator AgentsDrug DesignQuinazolinonesQuinazolinesAnimalsRatsStructure-Activity RelationshipMolecular Docking SimulationMolecular StructureMaleAortaModels, MolecularDose-Response Relationship, Drug

Stichwörter der Autor:innen

ADMEToxmolecular dockingmolecular dynamics simulationquinazolin‐4(3H)‐one‐1,2,3 triazolevasorelaxant

Substanzen

TriazolesVasodilator AgentsQuinazolinonesQuinazolines

Autor:innen und Institutionen

  • Engineering Laboratory of Organometallic, Molecular and Environment, Faculty of Sciences Dhar EL Mahraz, Sidi Mohamed Ben Abdellah University, Fes, Morocco.
  • Faculty of Chemistry and Chemical Engineering, Babeș-Bolyai University, Cluj-Napoca, Romania.
  • Team of Ethnopharmacology and Pharmacognosy, Faculty of Sciences and Techniques Errachidia, Moulay Ismail University of Meknes, Errachidia, Morocco.
  • Laboratory of Analytical and Molecular Chemistry, Faculty of Sciences Ben M'Sik, Hassan II University of Casablanca, Casablanca, Morocco.
  • Laboratory of Materials Engineering for the Environment and Natural Resources, Faculty of Sciences and Techniques, University of Moulay Ismail, Meknès, Morocco.
  • Laboratory of Bioorganic Chemistry, Department of Chemistry, Faculty of Sciences, Chouaïb Doukkali University, El Jadida, Morocco.

ORCID-Profile: Mohamed Bakhouch

Zitieren

APA

Rhazi, Y., Bouadid, I., Guerguer, F. Z., El Mesky, M., Arzine, A., Nakkabi, A., Bakhouch, M., Deak, N., Chtita, S., Mabrouk, E. H., Nemes, G., Yazidi, M. E., & Eddouks, M. (2025). Design, Synthesis, Characterization, Molecular Modeling, and ADMET Analysis of Novel Quinazolin‐4(3 H )‐One‐Triazole Hybrids as Vasorelaxant Agent. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202501062

Vancouver

Rhazi Y, Bouadid I, Guerguer FZ, El Mesky M, Arzine A, Nakkabi A, et al. Design, Synthesis, Characterization, Molecular Modeling, and ADMET Analysis of Novel Quinazolin‐4(3 H )‐One‐Triazole Hybrids as Vasorelaxant Agent. Chemistry & Biodiversity. 2025. doi:10.1002/cbdv.202501062

BibTeX
@article{Rhazi2025,
  author = {Rhazi, Yassine and Bouadid, Ismail and Guerguer, Fatima Zahra and El Mesky, Mohammed and Arzine, Aziz and Nakkabi, Asmae and Bakhouch, Mohamed and Deak, Noemi and Chtita, Samir and Mabrouk, El Houssine and Nemes, Gabriela and Yazidi, Mohamed El and Eddouks, Mohamed},
  title = {Design, Synthesis, Characterization, Molecular Modeling, and ADMET Analysis of Novel Quinazolin‐4(3 H )‐One‐Triazole Hybrids as Vasorelaxant Agent},
  journal = {Chemistry & Biodiversity},
  year = {2025},
  doi = {10.1002/cbdv.202501062}
}
Kostenlos starten →